Allogeneic B-cell therapy (Be Biopharma)

N/A

Report date: 2025/05/22 17:22:45

Base Information

Drug NameAllogeneic B-cell therapy (Be Biopharma)
Drug Alias NameEngineered B Cell Medicines therapy (Be Biopharma)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionLymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsRare DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBe Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesBe Biopharma Inc
Inactive CompaniesN/A
Active IndicationsRare DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A